EP3088002 - EXTENDED RELEASE FORMULATION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.11.2023 Database last updated on 16.07.2024 | |
Former | Examination is in progress Status updated on 17.12.2019 | Most recent event Tooltip | 24.11.2023 | Application deemed to be withdrawn | published on 27.12.2023 [2023/52] | Applicant(s) | For all designated states Shionogi & Co., Ltd. 1-8, Doshomachi 3-chome Chuo-ku Osaka-shi, Osaka 541-0045 / JP | [2016/44] | Inventor(s) | 01 /
MIZUTANI, Naoya 1-3 Kuise Terajima 2-chome Amagasaki-shi Hyogo 660-0813 / JP | 02 /
KIMURA, Go 1-3 Kuise Terajima 2-chome Amagasaki-shi Hyogo 660-0813 / JP | 03 /
NISHINO, Yukiko 1-3 Kuise Terajima 2-chome Amagasaki-shi Hyogo 660-0813 / JP | 04 /
SAKUMA, Satoshi 1-3 Kuise Terajima 2-chome Amagasaki-shi Hyogo 660-0813 / JP | [2016/44] | Representative(s) | Eder, Michael df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | [2016/44] | Application number, filing date | 15743275.8 | 30.01.2015 | [2016/44] | WO2015JP52632 | Priority number, date | JP20140017333 | 31.01.2014 Original published format: JP 2014017333 | [2016/44] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015115586 | Date: | 06.08.2015 | Language: | JA | [2015/31] | Type: | A1 Application with search report | No.: | EP3088002 | Date: | 02.11.2016 | Language: | EN | [2016/44] | Search report(s) | International search report - published on: | JP | 06.08.2015 | (Supplementary) European search report - dispatched on: | EP | 16.11.2017 | Classification | IPC: | A61K47/02, A61K9/16, A61K9/20, A61K47/38 | [2016/44] | CPC: |
A61K9/2054 (EP,US);
A61K31/167 (EP,US);
A61K31/192 (EP,US);
A61K31/4422 (US);
A61K9/2009 (US);
A61K9/2013 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/44] | Title | German: | FORMULIERUNGEN MIT ERWEITERTER FREISETZUNG | [2016/44] | English: | EXTENDED RELEASE FORMULATION | [2016/44] | French: | FORMULATION À LIBÉRATION PROLONGÉE | [2016/44] | Entry into regional phase | 29.07.2016 | Translation filed | 29.07.2016 | National basic fee paid | 29.07.2016 | Search fee paid | 29.07.2016 | Designation fee(s) paid | 29.07.2016 | Examination fee paid | Examination procedure | 29.07.2016 | Examination requested [2016/44] | 14.06.2018 | Amendment by applicant (claims and/or description) | 20.12.2019 | Despatch of a communication from the examining division (Time limit: M04) | 20.04.2020 | Reply to a communication from the examining division | 01.08.2023 | Application deemed to be withdrawn, date of legal effect [2023/52] | 22.08.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2023/52] | Fees paid | Renewal fee | 11.01.2017 | Renewal fee patent year 03 | 15.01.2018 | Renewal fee patent year 04 | 15.01.2019 | Renewal fee patent year 05 | 14.01.2020 | Renewal fee patent year 06 | 13.01.2021 | Renewal fee patent year 07 | 17.12.2021 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.01.2023 | 09   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US2004048896 (PHILLIPS JEFFREY OWEN [US]) [X] 1,11,12,15 * Formulation 17; paragraph [0329] - paragraph [0330] *; | [XA]US2007238716 (MURTHY AYANAMPUDI S R [IN], et al) [X] 3-5,7,9,11,12,15 * paragraphs [0004] , [ 0007] - paragraph [0025] * * paragraph [0034] - paragraph [0039] * * paragraph [0088] - paragraph [0099]; example 3 * * claims 1, 7, 8 * [A] 1,2; | [XI]JP4224866B (TAISHO PHARMA CO LTD) [X] 1,3-7,9,11,12,15 * paragraph [0001] - paragraph [0020] * * paragraph [0033] - paragraph [0034]; example 5 * * Experiment 5; paragraph [0046]; figure 5 * * claims 1-3 *[I] 2,8,10,13,14; | [X]US2009142398 (PHILIP MATHEW [CA], et al) [X] 1,3,5-7,9,11,12,15 * paragraph [0020] - paragraph [0030] * * Formulations B and C; paragraph [0091] - paragraph [0100] * * claim 1 * | International search | [X]JPH1081634 (TAISHO PHARMA CO LTD); | [X]JP2008515802 (SCOLR PHARMA, INC.); | [X]US2007141144 (ROBERTS MICHAEL S [AU], et al) | [X] - CHOI HAN-GON ET AL., "al.Formulation and in vivo evaluation of omeprazole buccal adhesive tablet", J.CONTROL.RELEASE, (2000), vol. 68, no. 3, pages 405 - 412, XP004208511 DOI: http://dx.doi.org/10.1016/S0168-3659(00)00275-3 | by applicant | JP2008500287 | JP2009517346 | - PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, (2014), vol. 19, no. 3, pages 285 - 289 |